Interbody fusion cages market to reach $2.98 billion by 2030

The interbody fusion cages market is projected to grow from $2.39 billion in 2025 to $2.51 billion in 2026, then to $2.98 billion by 2030, according to a new Business Research Company report. Demand is rising on the back of spinal cord injuries, aging populations, and broader use of minimally invasive spine surgery.

Why it matters: - Interbody fusion cages support spine stabilization in fusion surgery, making them central to treatment for degenerative spinal conditions, spinal injuries and chronic back pain. - The market’s steady growth signals rising demand for orthopedic implants as more patients and providers turn to surgical spine care.

What happened: - The Business Research Company released its Interbody Fusion Cages Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 on August 12, 2026. - The report values the market at $2.39 billion in 2025 and projects $2.51 billion in 2026. - The report forecasts the market will reach $2.98 billion by 2030. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company published a free sample report and the full market report.

The details: - The market grew at a 4.9% CAGR during the historical period, driven by degenerative spinal conditions, an aging population, more spinal injuries, expanded orthopedic surgical facilities and wider acceptance of spinal fusion techniques. - The forecast period implies a 4.4% CAGR through 2030. - Growth is expected to come from demand for minimally invasive spine surgeries, more chronic back pain cases, preference for surgical stabilization, wider access to advanced spinal care and greater focus on post-operative outcomes. - Key trends include rising adoption of spinal fusion surgeries, more minimally invasive procedures, stronger demand for titanium and polymer-based cages, broader use in lumbar and cervical fusion, and a shift toward anatomically designed cages. - Interbody fusion cages are implantable devices placed between vertebrae during spinal fusion to promote bone growth, provide structural support and help restore alignment and function. - The devices are made from biocompatible materials such as titanium or polymers. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period.

Between the lines: - Rising spinal cord injury prevalence is a major demand driver because these cases often require procedures that improve stability and encourage fusion. - NeoMotion, affiliated with IIT Madras Research Park, estimates about 105,000 people in the UK were living with spinal cord injuries in 2024. - The regional split suggests mature demand in North America and faster expansion in Asia-Pacific as healthcare access and surgical capability improve. - The report’s emphasis on anatomical design and minimally invasive procedures points to a market moving toward more patient-specific and less invasive implant solutions.

What’s next: - The market is likely to keep expanding as spinal surgery volumes rise and providers adopt newer cage materials and designs. - The strongest growth opportunity appears to be in Asia-Pacific as surgical infrastructure and access continue to build. - The report’s added forecasting tools, market scoring and trend analysis are aimed at helping suppliers and investors identify growth pockets and product priorities.

The bottom line: - Interbody fusion cages are set for moderate but durable growth, supported by an aging population, rising spinal disorders and broader use of advanced spine surgery.